New Details Deepens Concern
Avandia is currently the top-selling diabetic drug with total US sales of $2.2 billion in 2006. A one-month supply sells for between $90 and $170. Several months ago the New England Journal of Medicine (NEJM) revealed that Avandia is associated with a 43% increase in heart attacks and up to 64% increase in cardiovascular deaths. …